Bioactive Compounds Isolated from a Marine Sponge Selectively Inhibit Neisseria gonorrhoeae
- PMID: 39766619
- PMCID: PMC11726862
- DOI: 10.3390/antibiotics13121229
Bioactive Compounds Isolated from a Marine Sponge Selectively Inhibit Neisseria gonorrhoeae
Abstract
Background/objectives: Neisseria gonorrhoeae is the third most common sexually transmitted infection (STI), which may become untreatable soon if resistance continues to drastically increase. Due to increases in resistance to recommended antibiotics, alternative sources of novel compounds to combat this threat are being explored. Interestingly, marine sponges have proven to produce a plethora of bioactive compounds that display anticancer, antiviral, antifungal, and antibacterial activity.
Methods: In this study, the extracts of the sponge collected from Saint Thomas, US Virgin Islands were examined to determine their antibacterial activity against E. coli, S. aureus, and N. gonorrhoeae.
Results: The ethyl acetate sponge extracts significantly inhibited growth of N. gonorrhoeae, while none inhibited S. aureus and E. coli. The bioassay-guided purification of the ethyl acetate extract resulted in the isolation of 6-desmethyl-6-ethylspongosoritin A (1) and plakortone B (2). To determine if the pure sponge metabolite could improve the efficacy of ceftriaxone against a high-level ceftriaxone (HTX)-resistant gonococcal strain, an antibiotic checkerboard assay was done by combining various concentrations of either precursor fractions or the purified compound 2 with ceftriaxone. Plakortone B (2) and ceftriaxone acted in synergy against gonococcal strains and inhibited growth by increasing membrane permeability when exposed for 4 h and 24 h.
Conclusions: This suggests that marine sponges may serve as a source for novel bioactive compounds against antibiotic-resistant strains of N. gonorrhoeae, as well as improve the efficacy of currently prescribed antibiotics.
Keywords: antibiotic; bioactive; ceftriaxone; high-level ceftriaxone resistant; metabolite; minimal inhibitory concentration; natural products; sexually transmitted infections.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Antimicrobial Activity of Auranofin, Cannabidivarin, and Tolfenamic Acid against Multidrug-Resistant Neisseria gonorrhoeae.Microbiol Spectr. 2022 Dec 21;10(6):e0395222. doi: 10.1128/spectrum.03952-22. Epub 2022 Nov 9. Microbiol Spectr. 2022. PMID: 36350125 Free PMC article.
-
Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.Sex Transm Dis. 1997 Mar;24(3):142-8. doi: 10.1097/00007435-199703000-00004. Sex Transm Dis. 1997. PMID: 9132980
-
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1. MMWR Surveill Summ. 2016. PMID: 27414503
-
Future Prospects for Neisseria gonorrhoeae Treatment.Antibiotics (Basel). 2018 Jun 15;7(2):49. doi: 10.3390/antibiotics7020049. Antibiotics (Basel). 2018. PMID: 29914071 Free PMC article. Review.
-
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.Med Microbiol Immunol. 2020 Apr;209(2):95-108. doi: 10.1007/s00430-019-00651-4. Epub 2019 Dec 4. Med Microbiol Immunol. 2020. PMID: 31802195 Free PMC article. Review.
Cited by
-
Characterization and bioactivity potential of marine sponges (Biemna fistulosa, Callyspongia diffusa, and Haliclona fascigera) from Kenyan coastal waters.PLoS One. 2025 Jul 24;20(7):e0325642. doi: 10.1371/journal.pone.0325642. eCollection 2025. PLoS One. 2025. PMID: 40705799 Free PMC article.
References
-
- Cohen M.S., Hoffman I.F., Royce R.A., Kazembe P., Dyer J.R., Daly C.C., Zimba D., Vernazza P.L., Maida M., Fiscus S.A., et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet. 1997;349:1868–1873. doi: 10.1016/S0140-6736(97)02190-9. - DOI - PubMed
-
- Jones J., Weiss K., Mermin J., Dietz P., Rosenberg E.S., Gift T.L., Chesson H., Sullivan P.S., Lyles C., Bernstein K.T., et al. Proportion of Incident Human Immunodeficiency Virus Cases Among Men Who Have Sex With Men Attributable to Gonorrhea and Chlamydia: A Modeling Analysis. Sex. Transm. Dis. 2019;46:357–363. doi: 10.1097/OLQ.0000000000000980. - DOI - PMC - PubMed
-
- Centers for Disease Control and Prevention Drug Resistant Neisseria gonorrhoeae. [(accessed on 27 June 2024)];2019 Available online: https://www.cdc.gov/antimicrobial-resistance/media/pdfs/gonorrhea-508.pdf.
-
- Costa-Lourenco A., Barros Dos Santos K.T., Moreira B.M., Fracalanzza S.E.L., Bonelli R.R. Antimicrobial resistance in Neisseria gonorrhoeae: History, molecular mechanisms and epidemiological aspects of an emerging global threat. Braz. J. Microbiol. 2017;48:617–628. doi: 10.1016/j.bjm.2017.06.001. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources